3 Single Use Medical Devices Maker, Plywood and Laminates Maker and Shrimp Feed Maker Stocks With a Strong Future Roadmap: Poly Medicure, Century Plyboards (India) and Avanti Feeds
- November 6, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
Poly Medicure, Century Plyboards (India) and Avanti Feeds: ROE of 10.1% to 18.4% and FY22 to FY26 revenue CAGR of 5.2% to 20.0%. Prices as of 5 Nov 2026.
Quick Answer
The three medical device, plywood and shrimp feed stocks to watch are Poly Medicure, Century Plyboards (India) and Avanti Feeds. Their return on equity ranges from 10.1% to 18.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.2% to 20.0%. Avanti Feeds has the highest return on equity at 18.4%, while Poly Medicure has the fastest revenue growth at 20.0% a year. Prices are based on the 5 November 2026 close, and this article is educational, not investment advice.
Medical device, plywood and shrimp feed stocks offer a focused view of a sector where demand keeps widening. Poly Medicure, Century Plyboards (India) and Avanti Feeds cover a single use medical devices maker, a plywood and laminates maker and a shrimp feed maker.
This list covers three medical device, plywood and shrimp feed stocks with complete current figures: Poly Medicure, Century Plyboards (India) and Avanti Feeds. Every figure comes from the latest reported financials and the 5 November 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Medical Device, Plywood and Shrimp Feed Stocks?
Medical device, plywood and shrimp feed stocks are listed companies that make infusion sets, syringes and catheters, produce plywood, laminates and doors, and make shrimp feed and process seafood for export. Their earnings depend on hospital supply demand, housing and interior spending and aquaculture activity.
Medical Device, Plywood and Shrimp Feed Stocks at a Glance
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE (%) | D/E |
|---|---|---|---|---|---|---|
| Poly Medicure | 1,602.2 | 15,721 | 50.2 | 59.6 | 10.4 | 0.11 |
| Century Plyboards (India) | 649.85 | 14,715 | 49.3 | 36.3 | 10.1 | 0.68 |
| Avanti Feeds | 725.9 | 9,865 | 16.8 | 33.9 | 18.4 | 0.00 |
On valuation, Poly Medicure and Avanti Feeds trade at a P/E below the industry P/E, while Century Plyboards (India) trades above it, which reflects the growth the market already expects. Readers comparing medical device, plywood and shrimp feed stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain. With the Q2 FY27 results season close, investors in medical device, plywood and shrimp feed stocks can use the coming numbers to test whether growth is holding.
Why Do Medical Device, Plywood and Shrimp Feed Stocks Have a Strong Roadmap in India?
Medical device, plywood and shrimp feed stocks have a strong roadmap in India because wider hospital use of single-use devices, growing interior work in new homes and rising seafood exports keep widening the market for these companies.
- Medical devices. Hospitals use more single-use products.
- Plywood. New homes need furniture and interiors.
- Shrimp feed. Seafood exports keep growing.
Why Poly Medicure Features Among These Medical Device, Plywood and Shrimp Feed Stocks
Among the medical device, plywood and shrimp feed stocks on this list, Poly Medicure makes single-use medical devices such as infusion sets, syringes, catheters, blood management products and dialysis consumables, and it exports to many countries.
In the June 2026 quarter, revenue grew 25.5% year on year to Rs 559 crore. Revenue rose from Rs 961 crore in FY22 to Rs 1,995 crore in FY26, a compound annual growth rate of 20.0%.
Net profit grew from Rs 147 crore in FY22 to Rs 321 crore in FY26, which works out to a compound annual growth rate of 21.6%. The company has a return on equity of 10.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 15,721 crore. The stock trades at a P/E of 50.2, below the industry P/E of 59.6.
Roadmap: The company is adding capacity and new products, including dialysis and cardiology devices, and it is growing its presence with global hospital customers. Rising healthcare spending supports demand for disposable devices.
What to watch: Track export growth, new product approvals and plant capacity use.
Why Century Plyboards (India) Features Among These Medical Device, Plywood and Shrimp Feed Stocks
Among the healthcare, interiors and aquaculture shares on this list, Century Plyboards (India) is a leading maker of plywood, laminates, medium density fibreboard, particle board and doors, sold under the CenturyPly and Century Laminates brands.
The company has a return on equity of 10.1%, a debt to equity ratio of 0.68 and a market capitalisation of Rs 14,715 crore. The stock trades at a P/E of 49.3, above the industry P/E of 36.3.
Revenue rose from Rs 3,050 crore in FY22 to Rs 5,407 crore in FY26, a compound annual growth rate of 15.4%. Net profit grew from Rs 186 crore in FY25 to Rs 268 crore in FY26, a rise of 44.2%. In the June 2026 quarter, revenue grew 33.5% year on year to Rs 1,564 crore, while net profit rose 57.4% to Rs 83.3 crore.
Roadmap: Rising housing and furniture demand and a shift from unorganised to branded products support volumes across its wood panel range. Capacity added in laminates and fibreboard widens its reach in premium and mid-priced segments.
What to watch: Monitor volume growth in laminates and fibreboard and the utilisation of new plants.
Why Avanti Feeds Features Among These Medical Device, Plywood and Shrimp Feed Stocks
Among the three companies on this list, Avanti Feeds, based in Hyderabad, makes shrimp feed and also processes and exports shrimp, serving aquaculture farmers across India.
Revenue rose from Rs 5,118 crore in FY22 to Rs 6,276 crore in FY26, a compound annual growth rate of 5.2%. Net profit grew from Rs 245 crore in FY22 to Rs 656 crore in FY26, which works out to a compound annual growth rate of 27.9%.
In the June 2026 quarter, revenue grew 18.7% year on year to Rs 1,966 crore. The company has a return on equity of 18.4%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 9,865 crore. The stock trades at a P/E of 16.8, below the industry P/E of 33.9.
Roadmap: India’s aquaculture sector is growing, and demand for quality feed rises with it. The company has a large share of the domestic shrimp feed market and is expanding its processing and exports.
What to watch: Follow export demand and shrimp farm cycles, which affect feed volumes.
Poly Medicure vs Century Plyboards (India) vs Avanti Feeds on Key Financials
The table below sets the three medical device, plywood and shrimp feed stocks side by side on revenue, profit and margin, using reported figures.
| Company | FY22 Revenue (Rs Cr) | FY26 Revenue (Rs Cr) | Revenue CAGR (FY22-FY26) | FY26 Net Profit (Rs Cr) | FY26 Net Margin |
|---|---|---|---|---|---|
| Poly Medicure | 961 | 1,995 | 20.0% | 321 | 16.1% |
| Century Plyboards (India) | 3,050 | 5,407 | 15.4% | 268 | 5.0% |
| Avanti Feeds | 5,118 | 6,276 | 5.2% | 656 | 10.4% |
Avanti Feeds posts the highest return on equity in this group at 18.4%. Avanti Feeds has the largest FY26 revenue at Rs 6,276 crore, and Poly Medicure shows the fastest revenue growth with a 20.0% compound annual rate. A useful habit with medical device, plywood and shrimp feed stocks is to check each new quarterly result against the capacity plans the company described earlier.
The June 2026 quarter, the latest reported, gives a fresh read on momentum:
| Company | Q1 FY26 Revenue (Rs Cr) | Q1 FY27 Revenue (Rs Cr) | Year-on-Year Growth |
|---|---|---|---|
| Poly Medicure | 445 | 559 | 25.5% |
| Century Plyboards (India) | 1,171 | 1,564 | 33.5% |
| Avanti Feeds | 1,656 | 1,966 | 18.7% |
Key Risks to Check Before Investing in Medical Device, Plywood and Shrimp Feed Stocks
Every theme carries risks that deserve a check before any decision. For these medical device, plywood and shrimp feed stocks, the main points are: Long-term healthcare, interiors and aquaculture shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.
- Client concentration. A few large clients contribute a big share of revenue.
- Housing cycles. Real estate and building demand can vary with rates and sentiment.
- Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them.
Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.
Use the Univest Stock Screener to filter medical device, plywood and shrimp feed stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.
Final Thoughts on Medical Device, Plywood and Shrimp Feed Stocks
Medical device, plywood and shrimp feed stocks reward patient research into demand, execution and financial strength. Poly Medicure, Century Plyboards (India) and Avanti Feeds each have a clear plan to grow. Based on the 5 November 2026 close, Poly Medicure trades at Rs 1,602.2, Century Plyboards (India) at Rs 649.85 and Avanti Feeds at Rs 725.9. Valuation matters as much as growth, so compare each company’s P/E with its industry P/E before adding any of these medical device, plywood and shrimp feed stocks to a watchlist.
Download the Univest iOS App or Univest Android App to track medical device, plywood and shrimp feed stocks, set price alerts and get research-backed stock ideas.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
What are medical device, plywood and shrimp feed stocks?
Ans. Medical device, plywood and shrimp feed stocks are listed companies that make infusion sets, syringes and catheters, produce plywood, laminates and doors, and make shrimp feed and process seafood for export. Their earnings depend on hospital supply demand, housing and interior spending and aquaculture activity. This list looks at three of them, Poly Medicure, Century Plyboards (India) and Avanti Feeds, using reported FY22 to FY26 financials and the 5 November 2026 closing prices.
Which medical device, plywood and shrimp feed stocks are covered in this list?
Ans. This list covers Poly Medicure, Century Plyboards (India) and Avanti Feeds. Based on the 5 November 2026 close, Poly Medicure traded at Rs 1,602.2, Century Plyboards (India) at Rs 649.85 and Avanti Feeds at Rs 725.9. Their return on equity ranges from 10.1% to 18.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 5.2% to 20.0%.
Why do medical device, plywood and shrimp feed stocks have a strong future roadmap in India?
Ans. Medical device, plywood and shrimp feed stocks have a strong roadmap in India because wider hospital use of single-use devices, growing interior work in new homes and rising seafood exports keep widening the market for these companies. The main drivers are as follows. Medical devices. Hospitals use more single-use products. Plywood. New homes need furniture and interiors. Shrimp feed. Seafood exports keep growing. Together these factors give the companies on this list a visible path for growth over the coming years.
How has Poly Medicure performed financially?
Ans. Revenue rose from Rs 961 crore in FY22 to Rs 1,995 crore in FY26, a compound annual growth rate of 20.0%. Net profit grew from Rs 147 crore in FY22 to Rs 321 crore in FY26, which works out to a compound annual growth rate of 21.6%. In the June 2026 quarter, revenue grew 25.5% year on year to Rs 559 crore. The company has a return on equity of 10.4%, a debt to equity ratio of 0.11 and a market capitalisation of Rs 15,721 crore. The stock trades at a P/E of 50.2, below the industry P/E of 59.6. Looking ahead, the company is adding capacity and new products, including dialysis and cardiology devices, and it is growing its presence with global hospital customers. Rising healthcare spending supports demand for disposable devices.
How has Century Plyboards (India) performed financially?
Ans. Revenue rose from Rs 3,050 crore in FY22 to Rs 5,407 crore in FY26, a compound annual growth rate of 15.4%. Net profit grew from Rs 186 crore in FY25 to Rs 268 crore in FY26, a rise of 44.2%. In the June 2026 quarter, revenue grew 33.5% year on year to Rs 1,564 crore, while net profit rose 57.4% to Rs 83.3 crore. The company has a return on equity of 10.1%, a debt to equity ratio of 0.68 and a market capitalisation of Rs 14,715 crore. The stock trades at a P/E of 49.3, above the industry P/E of 36.3. Looking ahead, rising housing and furniture demand and a shift from unorganised to branded products support volumes across its wood panel range. Capacity added in laminates and fibreboard widens its reach in premium and mid-priced segments.
How has Avanti Feeds performed financially?
Ans. Revenue rose from Rs 5,118 crore in FY22 to Rs 6,276 crore in FY26, a compound annual growth rate of 5.2%. Net profit grew from Rs 245 crore in FY22 to Rs 656 crore in FY26, which works out to a compound annual growth rate of 27.9%. In the June 2026 quarter, revenue grew 18.7% year on year to Rs 1,966 crore. The company has a return on equity of 18.4%, a debt to equity ratio of 0.00 and a market capitalisation of Rs 9,865 crore. The stock trades at a P/E of 16.8, below the industry P/E of 33.9. Looking ahead, india’s aquaculture sector is growing, and demand for quality feed rises with it. The company has a large share of the domestic shrimp feed market and is expanding its processing and exports.
What risks should investors check before buying medical device, plywood and shrimp feed stocks?
Ans. Investors should check a few risks before buying medical device, plywood and shrimp feed stocks. Client concentration. A few large clients contribute a big share of revenue. Housing cycles. Real estate and building demand can vary with rates and sentiment. Valuation levels. Some of these companies trade at high earnings multiples, so growth must continue to justify them. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.
Is this list of medical device, plywood and shrimp feed stocks investment advice?
Ans. No. This article is educational and uses publicly available data as of the 5 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.
